Manulife (Manufacturers Life Insurance)’s CG Oncology CGON Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.24M	Buy	136,544 +8,066	+6%	+$457K	0.01%	882
2025 Q4	$5.2M	Buy	128,478 +17,560	+16%	+$727K	﹤0.01%	1151
2025 Q3	$4.47M	Sell	110,918 -42,954	-28%	-$1.25M	﹤0.01%	1223
2025 Q2	$4M	Buy	153,872 +76,437	+99%	+$1.84M	﹤0.01%	1263
2025 Q1	$1.9M	Buy	77,435 +913	+1%	+$25.7K	﹤0.01%	1506
2024 Q4	$2.19M	Buy	76,522 +3,373	+5%	+$115K	﹤0.01%	1521
2024 Q3	$2.76M	Buy	73,149 +12,848	+21%	+$450K	﹤0.01%	1436
2024 Q2	$1.9M	Sell	60,301 -3,473	-5%	-$120K	﹤0.01%	1514
2024 Q1	$2.8M	Buy	+63,774	New	+$2.6M	﹤0.01%	1394

Other funds holding CGON

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Manulife (Manufacturers Life Insurance)'s CGON Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its CG Oncology (CGON) stake by 6.3% in Q1 2026, buying an estimated $457K and bringing the position to 136,544 shares worth $9.24M. The position accounts for 0.01% of the portfolio, ranked #882.

Manulife (Manufacturers Life Insurance) first reported a position in CGON in Q1 2024 and has held it in 9 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

Manulife (Manufacturers Life Insurance) held 136,544 shares of CG Oncology worth $9.24M as of Q1 2026.
Manulife (Manufacturers Life Insurance) bought 8,066 CG Oncology shares in Q1 2026, an estimated $457K.
CG Oncology made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #882 holding.
Manulife (Manufacturers Life Insurance) first reported a position in CG Oncology in Q1 2024 and has held it in 9 quarters since.
233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.